Lab Notes: Trevena gets $15M triggered by first sale of drug in China; Braeburn launches opioid use disorder drug Brixadi

This week's Lab Notes has details on a new drug launch, a major cash infusion at a biopharm firm, a smaller investment in a medical device company, and more.